Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 73, Issue 12
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical and epidemiological research
Concise report
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up
Online download statistics by month:
Online download statistics by month: August 2014 to March 2024
Abstract
Full
Pdf
Aug 2014
750
44
154
Sep 2014
249
67
109
Oct 2014
317
39
71
Nov 2014
893
58
128
Dec 2014
352
43
62
Jan 2015
234
24
38
Feb 2015
143
33
43
Mar 2015
104
26
41
Apr 2015
89
17
32
May 2015
61
19
22
Jun 2015
43
8
17
Jul 2015
46
9
15
Aug 2015
59
15
16
Sep 2015
67
9
11
Oct 2015
58
7
16
Nov 2015
75
15
12
Dec 2015
118
7
14
Jan 2016
51
3
11
Feb 2016
43
7
9
Mar 2016
28
8
13
Apr 2016
32
2
6
May 2016
64
15
17
Jun 2016
97
7
18
Jul 2016
31
16
7
Aug 2016
40
10
9
Sep 2016
49
5
8
Oct 2016
39
14
10
Nov 2016
51
17
13
Dec 2016
39
10
5
Jan 2017
35
9
6
Feb 2017
40
13
10
Mar 2017
26
7
7
Apr 2017
45
5
5
May 2017
51
10
15
Jun 2017
34
13
9
Jul 2017
58
4
4
Aug 2017
92
5
10
Sep 2017
108
16
9
Oct 2017
105
11
8
Nov 2017
84
9
4
Dec 2017
76
7
6
Jan 2018
114
10
9
Feb 2018
79
6
7
Mar 2018
76
11
6
Apr 2018
45
9
8
May 2018
60
6
4
Jun 2018
73
9
7
Jul 2018
50
10
5
Aug 2018
49
4
3
Sep 2018
49
9
5
Oct 2018
80
13
8
Nov 2018
57
7
5
Dec 2018
50
3
5
Jan 2019
39
7
3
Feb 2019
67
11
9
Mar 2019
57
4
5
Apr 2019
94
6
6
May 2019
53
7
5
Jun 2019
39
3
4
Jul 2019
73
7
7
Aug 2019
62
2
2
Sep 2019
79
6
8
Oct 2019
95
10
5
Nov 2019
77
7
1
Dec 2019
78
5
7
Jan 2020
87
6
3
Feb 2020
54
6
2
Mar 2020
68
2
6
Apr 2020
55
4
5
May 2020
57
8
2
Jun 2020
34
6
4
Jul 2020
45
1
1
Aug 2020
18
4
1
Sep 2020
66
9
3
Oct 2020
75
12
5
Nov 2020
50
5
3
Dec 2020
35
1
1
Jan 2021
59
5
5
Feb 2021
57
3
2
Mar 2021
69
3
3
Apr 2021
48
2
2
May 2021
20
3
2
Jun 2021
14
8
5
Jul 2021
6
3
4
Aug 2021
11
4
1
Sep 2021
15
13
12
Oct 2021
41
4
4
Nov 2021
36
8
1
Dec 2021
31
2
0
Jan 2022
45
6
1
Feb 2022
33
2
0
Mar 2022
60
4
2
Apr 2022
55
1
1
May 2022
67
4
0
Jun 2022
66
4
5
Jul 2022
62
10
1
Aug 2022
83
12
5
Sep 2022
71
10
3
Oct 2022
56
5
0
Nov 2022
41
3
1
Dec 2022
43
7
0
Jan 2023
35
5
2
Feb 2023
97
5
3
Mar 2023
54
2
2
Apr 2023
33
4
3
May 2023
52
4
1
Jun 2023
28
2
2
Jul 2023
33
3
0
Aug 2023
41
1
0
Sep 2023
19
4
0
Oct 2023
47
11
0
Nov 2023
77
10
0
Dec 2023
108
18
1
Jan 2024
64
7
5
Feb 2024
33
6
1
Mar 2024
35
11
0
Total
9060
1118
1270
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF